<?xml version="1.0" encoding="UTF-8"?>
<p id="Par23">Ryu et al. (
 <xref ref-type="bibr" rid="CR100">2010a</xref>) reported that 95% methanolic extracts of the bark of 
 <italic>Tripterygium regelii</italic> Sprague &amp; Takeda remarkably inhibited SARS-CoV 3CL
 <sup>pro</sup> activity (&gt; 70% inhibition at 30 μg/ml) (Ryu et al. 
 <xref ref-type="bibr" rid="CR100">2010a</xref>). The active compounds of 
 <italic>T. regelii</italic> are four quinone-methide triterpenoid derivatives: celastrol, pristimerin, tingenone, and iguesterin (
 <bold>6</bold>) with IC
 <sub>50</sub> values of 10.3, 5.5, 9.9, and 2.6 μM, respectively, against SARS-CoV 3CL
 <sup>pro</sup> (Ryu et al. 
 <xref ref-type="bibr" rid="CR100">2010a</xref>).
</p>
